Apabetalone (RVX-208) Attenuates an Inflammatory Milieu that Enhances Adhesion of Monocytes to Endothelial Cells in Type 2 Diabetes Mellitus with Cardiovascular Disease Patients

被引：0
|
作者：
Tsujikawa, Laura
Kulikowski, Ewelina
Calosing, Cyrus
Wasiak, Sylwia
Gilham, Dean
Halliday, Christopher
Johansson, Jan O.
Sweeney, Michael
Wong, Norman C.
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-474-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
474-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] APABETALONE (RVX-208) ATTENUATES INFLAMMATORY MILIEU UNDERLYING ADHESION OF MONOCYTES TO ENDOTHELIAL CELLS IN TYPE 2 DIABETES MELLITUS WITH CARDIOVASCULAR DISEASE PATIENTS
    Tsujikawa, L.
    Kulikowski, E.
    Rakai, B.
    Fu, L.
    Das, S.
    Halliday, C.
    Sarsons, C.
    Daze, E.
    Wasiak, S.
    Gilham, D.
    Johansson, J.
    Sweeney, M.
    Wong, N. C. W.
    [J]. ATHEROSCLEROSIS, 2019, 287 : E252 - E252
  • [2] APABETALONE (RVX-208) MODULATES EPIGENETIC PROCESSES IN MONOCYTES AND ENDOTHELIAL CELLS AFFECTED BY DIABETES MELLITUS AND DIET THAT ENHANCE RISK OF CARDIOVASCULAR DISEASE (CVD)
    Halliday, Christopher
    Tsujikawa, Laura
    Kulikowski, Ewelina
    Calosing, Cyrus
    Wasiak, Sylwia
    Gilham, Dean
    Johansson, Jan
    Sweeney, Mike
    Wong, Norman
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1355 - 1355
  • [3] APABETALONE (RVX-208) ATTENUATES HYPERGLYCEMIA AND TMAO INDUCED ADHESION OF THP-1 MONOCYTES TO HUVEC ENDOTHELIAL CELLS
    Tsujikawa, L.
    Kulikowski, E.
    Calosing, C.
    Wasiak, S.
    Gilham, D.
    Halliday, C.
    Johansson, J.
    Sweeney, M.
    Wong, N.
    [J]. ATHEROSCLEROSIS, 2018, 275 : E167 - E167
  • [4] Apabetalone (RVX-208) Lowers Major Adverse Cardiovascular Events (MACE) in Diabetes Mellitus Patients with CVD by Attenuating Monocyte Adhesion to Endothelial Cells
    Tsujikawa, Laura
    Kulikowski, Ewelina
    Calosing, Cyrus
    Wasiak, Sylwia
    Gilham, Dean
    Halliday, Christopher
    Johansson, Jan O.
    Sweeney, Michael
    Wong, Norman C.
    [J]. DIABETES, 2018, 67
  • [5] Apabetalone (rvx-208) Decreases Risk of Major Adverse Cardiovascular Events in Diabetes Mellitus Patients With Cvd by Attenuating Monocyte Adhesion to Endothelial Cells
    Tsujikawa, Laura
    Kulikowski, Ewelina
    Calosing, Cyrus
    Wasiak, Sylwia
    Gilham, Dean
    Halliday, Christopher
    Johansson, Jan
    Sweeney, Mike
    Wong, Norman
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [6] BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
    Wasiak, Sylwia
    Dzobo, Kim E.
    Rakai, Brooke D.
    Kaiser, Yannick
    Versloot, Miranda
    Bahjat, Mahnoush
    Stotz, Stephanie C.
    Fu, Li
    Sweeney, Michael
    Johansson, Jan O.
    Wong, Norman C. W.
    Stroes, Erik S. G.
    Kroon, Jeffrey
    Kulikowski, Ewelina
    [J]. CLINICAL EPIGENETICS, 2020, 12 (01)
  • [7] BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
    Sylwia Wasiak
    Kim E. Dzobo
    Brooke D. Rakai
    Yannick Kaiser
    Miranda Versloot
    Mahnoush Bahjat
    Stephanie C. Stotz
    Li Fu
    Michael Sweeney
    Jan O. Johansson
    Norman C. W. Wong
    Erik S. G. Stroes
    Jeffrey Kroon
    Ewelina Kulikowski
    [J]. Clinical Epigenetics, 2020, 12
  • [8] Epigenetic Reader Inhibitor Apabetalone (RVX-208) Counters Proinflammatory Hyperactivation of Cd14+Monocytes From Patients With Type 2 Diabetes and Cardiovascular Disease
    Wasiak, Sylwia
    Dzobo, Kim E.
    Bahjat, Mahnoush
    Rakai, Brooke D.
    Kaiser, Yannick
    Versloot, Miranda
    Kroon, Jeffrey
    Stotz, Stephanie C.
    Tsujikawa, Laura M.
    Fu, Li
    Gilham, Dean
    Sarsons, Christopher D.
    Sweeney, Michael
    Johansson, Jan O.
    Wong, Norman C.
    Stroes, Erik S.
    Kulikowski, Ewelina
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40
  • [9] EPIGENETIC READER INHIBITOR APABETALONE (RVX-208) COUNTERS PROINFLAMMATORY HYPERACTIVATION OF CD14+MONOCYTES FROM PATIENTS WITH TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE
    Wasiak, Sylwia
    Dzobo, Kim E.
    Bahjat, Mahnoush
    Rakai, Brooke D.
    Kaiser, Yannick
    Versloot, Miranda
    Kroon, Jeffrey
    Stotz, Stephanie C.
    Tsujikawa, Laura M.
    Fu, Li
    Gilham, Dean
    Sarsons, Christopher D.
    Sweeney, Michael
    Johansson, Jan O.
    Wong, Norman C. W.
    Stroes, Erik S. G.
    Kulikowski, Ewelina
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2217 - 2217
  • [10] Apabetalone (RVX-208) an epigenetic modifier lowers risk ofMACE in diabetes patients with CVD by affecting monocyte adhesion to endothelial cells
    Wong, N. C. W.
    Tsujikawa, L.
    Kulikowski, E.
    Calosing, C.
    Wasiak, S.
    Gilham, D.
    Halliday, C.
    Johansson, J. O.
    Sweeney, M.
    [J]. DIABETOLOGIA, 2018, 61 : S67 - S67
12345